X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options.
Albert, Michael H; Bittner, Tanja C; Nonoyama, Shigeaki; Notarangelo, Lucia Dora; Burns, Siobhan; Imai, Kohsuke; Espanol, Teresa; Fasth, Anders; Pellier, Isabelle; Strauss, Gabriele; Morio, Tomohiro; Gathmann, Benjamin; Noordzij, Jeroen G; Fillat, Cristina; Hoenig, Manfred; Nathrath, Michaela; Meindl, Alfons; Pagel, Philipp; Wintergerst, Uwe; Fischer, Alain; Thrasher, Adrian J; Belohradsky, Bernd H; Ochs, Hans D.
; 115(16): 3231-8, 2010 Apr 22.
Artigo em Inglês | MEDLINE | ID: mdl-20173115
Efficacy and safety of pathogen-reduced platelet concentrates in children with cancer: a retrospective cohort study.
Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia.
How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013.
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5â years: integrated analysis of data from the global clinical trials.
Anticoagulation for people with cancer and central venous catheters.
A Sixth Modality of Infectious Disease: Contagious Cancer from Devils to Clams and Beyond.
Risk of cancer among firefighters in California, 1988-2007.
A framework for how environment contributes to cancer risk.
SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.
Platelet Counts during Pregnancy.